pimavanserin and Basal-Ganglia-Diseases

pimavanserin has been researched along with Basal-Ganglia-Diseases* in 1 studies

Other Studies

1 other study(ies) available for pimavanserin and Basal-Ganglia-Diseases

Article	Year
Aripiprazole's receptor pharmacology and extrapyramidal side effects. The American journal of psychiatry, 2008, Volume: 165, Issue:3 Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Piperazines; Piperidines; Positron-Emission Tomography; Psychomotor Agitation; Quinolones; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Urea	2008

Article

Year

Aripiprazole's receptor pharmacology and extrapyramidal side effects.

The American journal of psychiatry, 2008, Volume: 165, Issue:3

Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Piperazines; Piperidines; Positron-Emission Tomography; Psychomotor Agitation; Quinolones; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Urea

2008